Skip to main content

Together we are beating cancer

Donate now

Cancer News

Kat Arney

Kat joined Cancer Research UK in 2004, after spending six years as a laboratory researcher. Kat loves talking about science, and regularly comments in the media on the latest discoveries as well as giving talks to staff and supporters. She has since left Cancer Research UK to pursue a career as a freelance journalist and science writer.
Showing 12 out of 289 results
  • Science & Technology

Finding faults in the BRAF gene

Our research sparked a surge of interest in BRAF, a gene that's faulty in more than half of all malignant melanomas, and provided new leads for cancer drugs. Our research sparked a surge of interest in BRAF, a gene that's faulty in more than half of all malignant melanomas, and provided new leads for cancer drugs.

by Kat Arney | Analysis | 24 August 2009

24 August 2009

This entry is part 2 of 30 in the series Our milestones
Cancer Research UK logo

Researchers in Spain have published results showing that certain cannabinoids could hold promise for treating prostate cancer. Researchers in Spain have published results showing that certain cannabinoids could hold promise for treating prostate cancer.

by Kat Arney | Analysis | 19 August 2009

19 August 2009